Wakefield Asset Management Lllp Bausch Health Companies Inc. Transaction History

Wakefield Asset Management Lllp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$23.0 - $29.01 $184,000 - $232,080	-8,000 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$21.37 - $34.38 $170,960 - $275,040	8,000 New	8,000 $254,000
Q1 2020 May 12, 2020	SELL	$12.98 - $30.25 $103,840 - $242,000	-8,000 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$18.89 - $31.89 $151,120 - $255,120	8,000 New	8,000 $239,000

272

280M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.